Gelatin Nanoparticles with Enhanced Affinity for Calcium Phosphate

Macromolecular Bioscience
Kambiz FarbodSander C G Leeuwenburgh

Abstract

Gelatin nanoparticles can be tuned with respect to their drug loading efficiency, degradation rate, and release kinetics, which renders these drug carriers highly suitable for a wide variety of biomedical applications. The ease of functionalization has rendered gelatin an interesting candidate material to introduce specific motifs for selective targeting to specific organs, but gelatin nanoparticles have not yet been modified to increase their affinity to mineralized tissue. By means of conjugating bone-targeting alendronate to biocompatible gelatin nanoparticles, a simple method is developed for the preparation of gelatin nanoparticles which exhibit strong affinity to mineralized surfaces. It has been shown that the degree of alendronate functionalization can be tuned by controlling the glutaraldehyde crosslinking density, the molar ratio between alendronate and glutaraldehyde, as well as the pH of the conjugation reaction. Moreover, it has been shown that the affinity of gelatin nanoparticles to calcium phosphate increases considerably upon functionalization with alendronate. In summary, gelatin nanoparticles have been developed, which exhibit great potential for use in bone-specific drug delivery and regenerative medicine.

References

Oct 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D E HughesB F Boyce
Oct 23, 1997·Journal of Biomedical Materials Research·M YoshinariJ A Jansen
Jun 6, 2000·Advanced Drug Delivery Reviews·Y Ikada, Y Tabata
Feb 26, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ajay Kumar GuptaAdam S G Curtis
Sep 15, 2004·International Journal of Pharmaceutics·Muniyandy SaravananKalathil Sadasivan Pillai
Sep 24, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·F A DorkooshH E Junginger
Nov 4, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Simon YoungAntonios G Mikos
Jan 18, 2006·Journal of Vascular and Interventional Radiology : JVIR·Daniel Y Sze
Apr 18, 2006·Journal of Materials Science. Materials in Medicine·A K Bajpai, Jyoti Choubey
Apr 28, 2006·Drug Development and Industrial Pharmacy·A S Mundada, B K Shrikhande
Feb 28, 2007·Chemical Society Reviews·Sufeng ZhangHasan Uludağ
Jul 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Devang ThakorIchiro Nishimura
Dec 11, 2007·Ultrasonics Sonochemistry·Cedric GoldenstedtCyril Lafon
Mar 14, 2008·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Amandeep KaurAshok K Tiwary
May 20, 2008·International Journal of Pharmaceutics·Nalini M AnandeNarendra K Jain
Jun 24, 2008·Journal of Drug Targeting·Muniyandy SaravananKalathil Sadasivan Pillai
Aug 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carole BourquinStefan Endres
Feb 3, 2009·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Daocheng Wu, Mingxi Wan
Mar 5, 2009·Drug Development and Industrial Pharmacy·Yang FanLi Tao
Jun 18, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Matthew S IronsideStephen Byard
Jan 29, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Dan DingBaorui Liu
Mar 12, 2011·Advanced Materials·Huanan WangSander C G Leeuwenburgh
Jul 26, 2011·Journal of Colloid and Interface Science·Elisa Boanini, Adriana Bigi
Aug 3, 2011·Tissue Engineering. Part B, Reviews·Huanan WangJohn A Jansen
Feb 10, 2012·Advanced Drug Delivery Reviews·Stewart A Low, Jindřich Kopeček
Mar 1, 2012·Journal of Biomedical Materials Research. Part a·M Reza NejadnikSander C G Leeuwenburgh
Dec 26, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Huanan WangSander C G Leeuwenburgh
Jan 3, 2013·Advanced Materials·Daniel A HellerDaniel G Anderson
Aug 2, 2013·Tissue Engineering. Part B, Reviews·Kambiz FarbodSander C G Leeuwenburgh
Sep 17, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·So Jin LeeKwangmeyung Kim
Oct 8, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ahmed O Elzoghby
Apr 22, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marco SantoroAntonios G Mikos

❮ Previous
Next ❯

Citations

Apr 4, 2017·Journal of Biomedical Materials Research. Part a·Alessandro PoliniSander C G Leeuwenburgh
Sep 20, 2016·Macromolecular Rapid Communications·Mani DibaSander C G Leeuwenburgh
Dec 22, 2020·Medicinal Research Reviews·Farideh OrdikhaniNasim Annabi
Jun 6, 2017·Acta Biomaterialia·Mani DibaSander C G Leeuwenburgh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Kinam Park
Expert Opinion on Drug Delivery
Adriana Raffin PohlmannSilvia S Guterres
Journal of Controlled Release : Official Journal of the Controlled Release Society
Marco SantoroAntonios G Mikos
© 2022 Meta ULC. All rights reserved